-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Adient, Lowers Price Target to $23

Benzinga·11/05/2026 23:47:02
Listen to the news
JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $25 to $23.